Browse News
Filter News
Found 29 articles
-
Pfizer Reports Second-Quarter 2023 Results
8/1/2023
Pfizer Inc. reported financial results for the second quarter of 2023.
-
Medigene AG Reports Full-Year 2022 Financial Results and Provides Corporate Update
3/29/2023
Medigene AG, an early stage immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, reported financial results for the year ended December 31, 2022 and provided a corporate update.
-
Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress
3/28/2023
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT) today announced its financial results for the fourth quarter ended December 31, 2022, and provided corporate updates.
-
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update
3/27/2023
BioNTech SE reported financial results for the three months and full year ended December 31, 2022, and provided an update on its corporate progress.
-
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
1/31/2023
Pfizer Inc. (NYSE: PFE) reported exceptional financial results for fourth-quarter and full-year 2022 and provided 2023 financial guidance(4).
-
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
11/7/2022
BioNTech SE reported financial results for the three and nine months ended September 30, 2022 and provided an update on its corporate progress.
-
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
11/1/2022
Pfizer Inc. reported solid financial results for third-quarter 2022 and updated certain components of 2022 financial guidance.
-
BioNTech Announces Second Quarter 2022 Financial Results and Corporate Update
8/8/2022
BioNTech SE reported financial results for the three and six months ended June 30, 2022 and provided an update on its corporate progress.
-
Pfizer Reports Second-Quarter 2022 Results
7/28/2022
Pfizer Inc. reported strong financial results for second-quarter 2022 and updated certain components of 2022 financial guidance.
-
Moderna announced its Omicron-containing COVID-19 booster candidate, mRNA-1273.214, demonstrated superior antibody response against Omicron in its Phase II/III study.
-
BioNTech Announces First Quarter Financial 2022 Results and Corporate Update
5/9/2022
BioNTech SE reported financial results for the three months ended March 31, 2022 and provided an update on its corporate progress.
-
Pfizer Reports First-Quarter 2022 Results
5/3/2022
Pfizer Inc. reported strong financial results for first-quarter 2022 and updated certain components of 2022 financial guidance.
-
After manufacturing more than 2.6 billion doses of the Comirnaty COVID-19 vaccine together, Pfizer’s partner BioNTech is reporting skyrocketing profits.
-
BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
3/30/2022
BioNTech SE reported financial results for the three months and full year ended December 31, 2021 and provided an update on its corporate progress.
-
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
3/16/2022
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2021 on Wednesday, March 30th, 2022.
-
Five Top CEOs to Watch in 2022
2/23/2022
Several CEOs have stood out from their peers throughout the past year, winning recognition from the Healthcare Technology Report. BioSpace looks at five of these leaders. -
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
2/8/2022
Pfizer Inc. (NYSE: PFE) reported strong financial results for fourth-quarter and full-year 2021 and provided 2022 total company financial guidance(4).
-
CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2021 and Provides Business Update
11/19/2021
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid, announced financial results for the third quarter and first nine months of 2021 and provided a business update.
-
BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
11/9/2021
BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update
-
PFIZER REPORTS THIRD-QUARTER 2021 RESULTS
11/2/2021
Pfizer Inc. reported financial results for third-quarter 2021 and raised 2021 guidance(4) for revenues and Adjusted diluted EPS(3)